Diffusion of Antipsychotics in the U.S. and French Markets, 1998–2008

Abstract

These results highlight markedly divergent trends in the diffusion of new antipsychotics in France and the United States. Some differences may be explained by differences in health systems; others may reflect physicians' preferences and norms of practice.